| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,028 | 1,185 | 1,751 | 2,851 | | Cost of Revenue | 1,648 | 848 | 1,251 | 1,660 | | | Gross Profit | 1,380 | 337 | 500 | 1,192 | | | Operating Expenses | | Research Development | 647 | 529 | 475 | 743 | | Selling General and Administrative | 1,282 | 1,130 | 1,200 | 1,562 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (549) | (1,322) | (1,175) | (1,113) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 29 | 46 | 38 | 73 | | Earnings Before Interest And Taxes | (520) | (1,276) | (1,137) | (1,040) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (520) | (1,276) | (1,137) | (1,040) | | Income Tax Expense | (182) | (444) | (397) | (354) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (338) | (832) | (740) | (686) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (338) | (832) | (740) | (686) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($338) | ($832) | ($740) | ($686) |
|
0.51% Nasdaq 
Income Statement
